ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 58 filers reported holding ADC THERAPEUTICS SA in Q4 2021. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,000 | -63.6% | 8,085 | -20.1% | 0.00% | – |
| Q2 2023 | $22,000 | +57.1% | 10,124 | +44.6% | 0.00% | – |
| Q1 2023 | $14,000 | -33.3% | 7,003 | +24.4% | 0.00% | – |
| Q4 2022 | $21,000 | +133.3% | 5,630 | +182.8% | 0.00% | – |
| Q3 2022 | $9,000 | -25.0% | 1,991 | +33.5% | 0.00% | – |
| Q2 2022 | $12,000 | -7.7% | 1,491 | +67.3% | 0.00% | – |
| Q1 2022 | $13,000 | +30.0% | 891 | +86.0% | 0.00% | – |
| Q4 2021 | $10,000 | -58.3% | 479 | -45.4% | 0.00% | – |
| Q3 2021 | $24,000 | +100.0% | 877 | +83.9% | 0.00% | – |
| Q2 2021 | $12,000 | +9.1% | 477 | +11.7% | 0.00% | – |
| Q1 2021 | $11,000 | +1000.0% | 427 | +1840.9% | 0.00% | – |
| Q3 2020 | $1,000 | – | 22 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,186,215 | $9,430,000 | 5.29% |
| GCM Grosvenor Holdings, LLC | 1,298,012 | $10,319,000 | 2.33% |
| Redmile Group, LLC | 7,512,029 | $59,721,000 | 2.28% |
| MPM BioImpact LLC | 334,384 | $2,658,000 | 0.74% |
| Indie Asset Partners, LLC | 93,989 | $747,000 | 0.66% |
| Eventide Asset Management | 1,879,959 | $14,946,000 | 0.32% |
| Walleye Capital LLC | 888,700 | $7,065,000 | 0.20% |
| Endurant Capital Management LP | 58,967 | $469,000 | 0.16% |
| HHLR ADVISORS, LTD. | 500,000 | $3,975,000 | 0.08% |
| Matrix Capital Management Company, LP | 400,000 | $3,180,000 | 0.07% |